InvestorsHub Logo
Followers 3
Posts 549
Boards Moderated 0
Alias Born 04/30/2009

Re: DSherman post# 360864

Saturday, 08/28/2021 4:51:17 PM

Saturday, August 28, 2021 4:51:17 PM

Post# of 401568
No. Nasrat put the company in "limp-mode", whereby demands upon
him are relatively few.. . . He certainly could do a number of things about any purported manipulation as he has over 300 million shares. As the CEO he could comment upon the stock price through a "letter-to-shareholders" if he weren't a profound example of what is wrong in the pharmaceutical industry today. Nasrat is definitely part of the problem rather than the solution. All of which is somewhat moot as "manipulation" is vastly different than "lack of interest". The latter being something Nasrat must have an acute awareness of vis-a-vis his treatment of both shareholders and his responsibilities as CEO.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News